Rating History for AMAG Pharmaceuticals (AMAg) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for AMAg
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/1/2020 Christopher J. Raymond Upgrade Neutral
(Underweight)		 13.75
(8.00)		 9.40
(13.75)		 46.28% Details